{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:56:55Z","timestamp":1793145415380,"version":"4.5.0"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005123","name":"Japanese Society of Nephrology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005123","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Renal Association"},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00469"],"award-info":[{"award-number":["PI22\/00469"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00050"],"award-info":[{"award-number":["PI22\/00050"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00251"],"award-info":[{"award-number":["PI21\/00251"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD21\/0005\/0001"],"award-info":[{"award-number":["RD21\/0005\/0001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD24\/0004\/0001"],"award-info":[{"award-number":["RD24\/0004\/0001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["PMP21\/00109"],"award-info":[{"award-number":["PMP21\/00109"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"COST","doi-asserted-by":"publisher","award":["CA21165"],"award-info":[{"award-number":["CA21165"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"COST","doi-asserted-by":"publisher","award":["101101220"],"award-info":[{"award-number":["101101220"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"COST","doi-asserted-by":"publisher","award":["101137054"],"award-info":[{"award-number":["101137054"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"COST","doi-asserted-by":"publisher","award":["101168626"],"award-info":[{"award-number":["101168626"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,27]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) is among the fastest growing global causes of death, forecasted to become the third leading cause of death in Western Europe and Japan by 2050. In contrast, mortality from cardiovascular disease is decreasing. Cardiovascular medicine is focused on identifying people at high risk and intervening to prevent cardiovascular events. The focus of kidney medicine has evolved over time. Last century the focus was on treating kidney failure by kidney replacement therapy (KRT). However, KRT outcomes are suboptimal. Life expectancy is up to 44 (women on dialysis) to 22\u00a0years (women with functioning kidney grafts) shorter on KRT than in the general population. The 21st century has witnessed an explosion of highly effective kidney-protective drugs that may both prevent and slow the progression of CKD while addressing the full cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome spectrum, i.e. also improving cardiovascular and metabolic outcomes. However, these advances have met a barrier: 20th century concepts on whom to test for CKD, which focus on assessing albuminuria just in people with diabetes mellitus. This outdated concept limits early diagnosis and treatment in up to 80% of people who eventually develop kidney failure. Clinical trials suggest that starting kidney protective therapy because CKD was diagnosed based on albuminuria, when glomerular filtration rate is normal, may delay the need for KRT for up to nearly 3\u00a0decades, meaning that many older subjects would not require KRT. To improve outcomes, the next two steps in kidney medicine should involve the widespread adoption of the ABCDE (albuminuria, blood pressure, cholesterol, diabetes and estimated glomerular filtration rate) approach for early detection and treatment of CKM risk, followed by developing the concept of pre-CKD that may guide pharmacologic interventions targeted to prevent CKD, on top of healthy lifestyle measures for the entire population, not just for those at risk.<\/jats:p>","DOI":"10.1093\/ndt\/gfaf151","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T11:45:17Z","timestamp":1754567117000},"page":"418-427","source":"Crossref","is-referenced-by-count":16,"title":["Evolving strategies for early diagnosis, proactive prevention and treatment of CKD"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-9523","authenticated-orcid":false,"given":"Alberto","family":"Ortiz","sequence":"first","affiliation":[{"name":"Health Research Institute-Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM) Department of Nephrology and Hypertension, , Madrid ,","place":["Spain"]},{"name":"RICORS2040-Renal, Madrid ,","place":["Spain"]},{"name":"Universidad Aut\u00f3noma de Madrid Departamento de Medicina, Facultad de Medicina, , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-9008","authenticated-orcid":false,"given":"Motoko","family":"Yanagita","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine, Kyoto University Department of Nephrology, , Kyoto ,","place":["Japan"]},{"name":"Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8343-9737","authenticated-orcid":false,"given":"Hideki","family":"Yokoi","sequence":"additional","affiliation":[{"name":"Kumamoto University Graduate School of Medical Sciences Department of Nephrology, , Kumamoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8714-2332","authenticated-orcid":false,"given":"Roser","family":"Torra","sequence":"additional","affiliation":[{"name":"RICORS2040-Renal, Madrid ,","place":["Spain"]},{"name":"Universitat Aut\u00f2noma de Barcelona, RICORS2040-Renal Nephrology Department, Fundaci\u00f3 Puigvert, Institut de Recerca Sant Pau (IR-Sant Pau), Departament de Medicina, , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"2026022705020047700_bib1","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/ndt\/gfae083","article-title":"Kidney health matters: a global imperative for public health","volume":"39","author":"Torra","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026022705020047700_bib2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"2026022705020047700_bib3","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/ndt\/gfz174","article-title":"A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases","volume":"34","author":"Jager","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2026022705020047700_bib4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/ndt\/gfad216","article-title":"CKD as a risk factor for severe COVID-19: a critical look back and lessons for the future","volume":"39","author":"Ortiz","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026022705020047700_bib5","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Writing Group for the CKD Prognosis Consortium","year":"2023","journal-title":"JAMA"},{"key":"2026022705020047700_bib6","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","article-title":"Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease Study 2021","volume":"403","author":"GBD 2021 Forecasting Collaborators","year":"2024","journal-title":"Lancet"},{"key":"2026022705020047700_bib7","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"2026022705020047700_bib8","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.kint.2025.02.025","article-title":"Age- and sex-specific reference values of estimated glomerular filtration rate for European adults","volume":"107","author":"Astley","year":"2025","journal-title":"Kidney Int"},{"key":"2026022705020047700_bib9","doi-asserted-by":"publisher","first-page":"sfae053","DOI":"10.1093\/ckj\/sfae053","article-title":"Decreased life expectancy: a health outcome not corrected by kidney replacement therapy that emphasizes the need for primary prevention of CKD","volume":"17","author":"Cordero","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026022705020047700_bib10","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2026022705020047700_bib11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/ndt\/gfac257","article-title":"Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association","volume":"38","author":"Ortiz","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026022705020047700_bib12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.nefroe.2023.06.005","article-title":"The Spanish Scientific Societies before the ESC 2021 guidelines on vascular disease prevention: generalizing the measurement of albuminuria to identify vascular risk and prevent vascular disease","volume":"43","author":"Ortiz","year":"2023","journal-title":"Nefrolog\u00eda (Engl Ed)"},{"key":"2026022705020047700_bib13","doi-asserted-by":"publisher","first-page":"gfaf057","DOI":"10.1093\/ndt\/gfaf057","article-title":"ABCDE to identify and prevent chronic kidney disease: a call to action","author":"Ferro","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026022705020047700_bib14","doi-asserted-by":"publisher","first-page":"S0085-2538(25)00334-5","DOI":"10.1016\/j.kint.2025.04.005","article-title":"Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","author":"Ortiz","year":"2025","journal-title":"Kidney Int"},{"key":"2026022705020047700_bib15","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/15598276221087672","article-title":"Healthy from the start-lifestyle interventions in early childhood","volume":"16","author":"Dalal","year":"2022","journal-title":"Am J Lifestyle Med"},{"key":"2026022705020047700_bib16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/ckj\/sfab240","article-title":"More on the invisibility of chronic kidney disease\u2026and counting","volume":"15","author":"Carriazo","year":"2022","journal-title":"Clin Kidney J"},{"key":"2026022705020047700_bib17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/ckj\/sfab210","article-title":"Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care","volume":"15","author":"Bosi","year":"2022","journal-title":"Clin Kidney J"},{"key":"2026022705020047700_bib18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/ndt\/gfae041","article-title":"A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) guidelines for the management of arterial hypertension","volume":"39","author":"Sarafidis","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"1 Suppl 1","key":"2026022705020047700_bib19","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.2337\/dc25-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","journal-title":"Diabetes Care"},{"issue":"1 Suppl 1","key":"2026022705020047700_bib20","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.2337\/dc25-S003","article-title":"3. Prevention or delay of diabetes and associated comorbidities: standards of care in diabetes\u20142025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","journal-title":"Diabetes Care"},{"key":"2026022705020047700_bib21","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1161\/HYPERTENSIONAHA.121.17323","article-title":"Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium","volume":"78","author":"Shin","year":"2021","journal-title":"Hypertension"},{"key":"2026022705020047700_bib22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nefroe.2025.01.002","article-title":"Cardiovascular risk assessment: missing albuminuria contributing to gender inequality","volume":"45","author":"de Sequera","year":"2025","journal-title":"Nefrolog\u00eda (Engl Ed)"},{"key":"2026022705020047700_bib23","doi-asserted-by":"publisher","first-page":"sfae405","DOI":"10.1093\/ckj\/sfae405","article-title":"The ERA Registry annual report 2022: epidemiology of kidney replacement therapy in Europe, with a focus on sex comparisons","volume":"18","author":"Boenink","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026022705020047700_bib24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s41100-024-00585-5","article-title":"Annual dialysis data report 2021, Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry","volume":"10","author":"Hanafusa","year":"2024","journal-title":"Ren Replace Ther"},{"key":"2026022705020047700_bib25","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/ndt\/gfae008","article-title":"Uromodulin biology","volume":"39","author":"Karagiannidis","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026022705020047700_bib26","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1093\/ndt\/gfad050","article-title":"The association of urinary epidermal growth factors with ADPKD disease severity and progression","volume":"38","author":"Harskamp","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"4 Suppl","key":"2026022705020047700_bib27","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"key":"2026022705020047700_bib28","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/jama.2012.16817","article-title":"Age and association of kidney measures with mortality and end-stage renal disease","volume":"308","author":"Hallan","year":"2012","journal-title":"JAMA"},{"key":"2026022705020047700_bib29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"2026022705020047700_bib30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"EMPA-KIDNEY Collaborative Group","year":"2023","journal-title":"N Engl J Med"},{"key":"2026022705020047700_bib31","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/ckj\/sfad082","article-title":"EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors","volume":"16","author":"Fern\u00e1ndez-Fernandez","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026022705020047700_bib32","doi-asserted-by":"publisher","first-page":"ii19","DOI":"10.1093\/ckj\/sfae296","article-title":"GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity","volume":"17","author":"Abasheva","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026022705020047700_bib33","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/ckj\/sfaa198","article-title":"SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia","volume":"13","author":"Fernandez-Fernandez","year":"2020","journal-title":"Clin Kidney J"},{"key":"2026022705020047700_bib34","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.7326\/M23-1023","article-title":"Impact of finerenone-induced albuminuria reduction on chronic kidney disease outcomes in type 2 diabetes : a mediation analysis","volume":"176","author":"Agarwal","year":"2023","journal-title":"Ann Intern Med"},{"key":"2026022705020047700_bib35","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1093\/ndt\/gfx376","article-title":"Albumin downregulates Klotho in tubular cells","volume":"33","author":"Fernandez-Fernandez","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2026022705020047700_bib36","doi-asserted-by":"publisher","first-page":"116203","DOI":"10.1016\/j.bcp.2024.116203","article-title":"Butyrate promotes kidney resilience through a coordinated kidney protective response in tubular cells","volume":"224","author":"Favero","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"2026022705020047700_bib37","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1681\/ASN.2014050465","article-title":"Klotho and phosphate are modulators of pathologic uremic cardiac remodeling","volume":"26","author":"Hu","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2026022705020047700_bib38","doi-asserted-by":"publisher","first-page":"113677","DOI":"10.1016\/j.biopha.2022.113677","article-title":"Sodium-glucose co-transporter-2 inhibitors increase Klotho in patients with diabetic kidney disease: a clinical and experimental study","volume":"154","author":"Mora-Fern\u00e1ndez","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"2026022705020047700_bib39","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1159\/000355728","article-title":"25-Hydroxyvitamin D3 1-\u03b1-hydroxylase-dependent stimulation of renal klotho expression by spironolactone","volume":"37","author":"Alesutan","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"2026022705020047700_bib40","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1681\/ASN.2015010093","article-title":"Antiaging gene klotho regulates adrenal CYP11B2 expression and aldosterone synthesis","volume":"27","author":"Zhou","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2026022705020047700_bib41","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41581-024-00837-x","article-title":"Post-translational modifications in kidney diseases and associated cardiovascular risk","volume":"20","author":"Noels","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"2026022705020047700_bib42","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes CKD Work Group","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"2026022705020047700_bib43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.nefroe.2022.07.003","article-title":"Information and consensus document for the detection and management of chronic kidney disease","volume":"42","author":"Garc\u00eda-Maset","year":"2022","journal-title":"Nefrolog\u00eda (Engl Ed)"},{"key":"2026022705020047700_bib44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clinbiochem.2019.04.012","article-title":"Laboratory intervention to improve the request of urinary albumin in primary care patients with arterial hypertension and financial implications","volume":"69","author":"Salinas","year":"2019","journal-title":"Clin Biochem"},{"key":"2026022705020047700_bib45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1515\/cclm-2018-0546","article-title":"Urinary albumin strip assay as a screening test to replace quantitative technology in certain conditions","volume":"57","author":"Salinas","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"2026022705020047700_bib46","doi-asserted-by":"publisher","first-page":"102414","DOI":"10.1016\/j.eclinm.2023.102414","article-title":"Cost-effectiveness of home-based screening of the general population for albuminuria to prevent progression of cardiovascular and kidney disease","volume":"68","author":"Pouwels","year":"2024","journal-title":"EClinicalMedicine"},{"key":"2026022705020047700_bib47","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/S0140-6736(23)00876-0","article-title":"Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS): a prospective, randomised, open-label implementation study","volume":"402","author":"van Mil","year":"2023","journal-title":"Lancet"},{"key":"2026022705020047700_bib48","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/S1470-2045(19)30639-4","article-title":"Cancer awareness crusades-pink ribbons and growing moustaches","volume":"20","author":"Cacciamani","year":"2019","journal-title":"Lancet Oncol"},{"key":"2026022705020047700_bib49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.23876\/j.krcp.23.127","article-title":"School urinary screening program in Japan: history, outcomes, perspectives","volume":"43","author":"Honda","year":"2024","journal-title":"Kidney Res Clin Pract"},{"key":"2026022705020047700_bib50","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10157-023-02412-3","article-title":"Higher participation rates for specific health checkups are associated with a lower incidence of treated end-stage kidney disease in Japan","volume":"28","author":"Wakasugi","year":"2024","journal-title":"Clin Exp Nephrol"},{"key":"2026022705020047700_bib51","article-title":"Semaglutide for managing overweight and obesity","author":"National Institute for Health and Care Excellence","year":"2023"},{"key":"2026022705020047700_bib52","doi-asserted-by":"publisher","first-page":"gfaf053","DOI":"10.1093\/ndt\/gfaf053","article-title":"Very low SBP targets and the boom-and-bust cycle of benefit and adverse kidney events","author":"Fernandez-Fernandez","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026022705020047700_bib53","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2215\/CJN.14901219","article-title":"Empagliflozin and cardiovascular and kidney outcomes across KDIGO risk categories: post hoc analysis of a randomized, double-blind, placebo-controlled, multinational trial","volume":"15","author":"Levin","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026022705020047700_bib54","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.2337\/dc22-0382","article-title":"Dapagliflozin and prevention of kidney disease among patients with type 2 diabetes: post hoc analyses from the DECLARE-TIMI 58 trial","volume":"45","author":"Mosenzon","year":"2022","journal-title":"Diabetes Care"},{"key":"2026022705020047700_bib55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1053\/j.ajkd.2020.06.018","article-title":"Relative and absolute risk reductions in cardiovascular and kidney outcomes with canagliflozin across KDIGO risk categories: findings from the CANVAS Program","volume":"77","author":"Neuen","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2026022705020047700_bib56","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3390\/ph17101299","article-title":"Glucose-lowering drugs and primary prevention of chronic kidney disease in type 2 diabetes patients: a real-world primary care study","volume":"17","author":"Rodr\u00edguez-Miguel","year":"2024","journal-title":"Pharmaceuticals"},{"key":"2026022705020047700_bib57","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/eurheartj\/ehab456","article-title":"Use of chronic kidney disease blind spot to prevent cardiorenal outcomes","volume":"43","author":"Ruilope","year":"2022","journal-title":"Eur Heart J"},{"key":"2026022705020047700_bib58","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2337\/dc22-0698","article-title":"Development and validation of prediction models of adverse kidney outcomes in the population with and without diabetes","volume":"45","author":"Grams","year":"2022","journal-title":"Diabetes Care"},{"key":"2026022705020047700_bib59","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1681\/ASN.0000000000000377","article-title":"Individualized risk of CKD progression among US adults","volume":"35","author":"Tio","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2026022705020047700_bib60","article-title":"Early detection of breast cancer","author":"Comunidad de Madrid"},{"key":"2026022705020047700_bib61","article-title":"Breast cancer screening in the Netherlands: a health economic evaluation of screening strategies","author":"Van Weezel","year":"2023"},{"key":"2026022705020047700_bib62","article-title":"Reducing the burden of non-communicable disease through kidney health promotion and disease prevention. Draft resolution proposed by Guatemala"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfaf151\/63991533\/gfaf151.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/3\/418\/63991533\/gfaf151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/3\/418\/63991533\/gfaf151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:02:13Z","timestamp":1772186533000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/3\/418\/8228479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":62,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,8,8]]},"published-print":{"date-parts":[[2026,2,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaf151","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,8,8]]}}}